Analyzing array data using supervised methods
Ringnér, Markus LU
; Peterson, Carsten
LU
and Khan, J
(2002)
In Pharmacogenomics
3(3).
p.403-415
- Abstract
- Pharmacogenomics is the application of genomic technologies to drug discovery and development, as well as for the elucidation of the mechanisms of drug action on cells and organisms. DNA microarrays measure genome-wide gene expression patterns and are an important tool for pharmacogenomic applications, such as the identification of molecular targets for drugs, toxicological studies and molecular diagnostics. Genome-wide investigations generate vast amounts of data and there is a need for computational methods to manage and analyze this information. Recently, several supervised methods, in which other information is utilized together with gene expression data, have been used to characterize genes and samples. The choice of analysis methods... (More)
- Pharmacogenomics is the application of genomic technologies to drug discovery and development, as well as for the elucidation of the mechanisms of drug action on cells and organisms. DNA microarrays measure genome-wide gene expression patterns and are an important tool for pharmacogenomic applications, such as the identification of molecular targets for drugs, toxicological studies and molecular diagnostics. Genome-wide investigations generate vast amounts of data and there is a need for computational methods to manage and analyze this information. Recently, several supervised methods, in which other information is utilized together with gene expression data, have been used to characterize genes and samples. The choice of analysis methods will influence the results and their interpretation, therefore it is important to be familiar with each method, its scope and limitations. Here, methods with special reference to applications for pharmacogenomics are reviewed. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/336182
- author
- Ringnér, Markus
LU
; Peterson, Carsten
LU
and Khan, J
- organization
- publishing date
- 2002-05
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- machine learning, genes, drug targets, DNA chip, diagnostic prediction, diagnostic classification, artificial neural networks, bioinformatics, microarray, support vector machines, target identification
- in
- Pharmacogenomics
- volume
- 3
- issue
- 3
- pages
- 403 - 415
- publisher
- Future Medicine Ltd.
- external identifiers
-
- wos:000175888400017
- scopus:0036262111
- pmid:12052147
- ISSN
- 1462-2416
- DOI
- 10.1517/14622416.3.3.403
- language
- English
- LU publication?
- yes
- id
- 356bf750-9ddf-4ff4-88b7-59eae32c8f59 (old id 336182)
- date added to LUP
- 2016-04-01 11:58:11
- date last changed
- 2023-01-03 01:58:44
@article{356bf750-9ddf-4ff4-88b7-59eae32c8f59,
abstract = {{Pharmacogenomics is the application of genomic technologies to drug discovery and development, as well as for the elucidation of the mechanisms of drug action on cells and organisms. DNA microarrays measure genome-wide gene expression patterns and are an important tool for pharmacogenomic applications, such as the identification of molecular targets for drugs, toxicological studies and molecular diagnostics. Genome-wide investigations generate vast amounts of data and there is a need for computational methods to manage and analyze this information. Recently, several supervised methods, in which other information is utilized together with gene expression data, have been used to characterize genes and samples. The choice of analysis methods will influence the results and their interpretation, therefore it is important to be familiar with each method, its scope and limitations. Here, methods with special reference to applications for pharmacogenomics are reviewed.}},
author = {{Ringnér, Markus and Peterson, Carsten and Khan, J}},
issn = {{1462-2416}},
keywords = {{machine learning; genes; drug targets; DNA chip; diagnostic prediction; diagnostic classification; artificial neural networks; bioinformatics; microarray; support vector machines; target identification}},
language = {{eng}},
number = {{3}},
pages = {{403--415}},
publisher = {{Future Medicine Ltd.}},
series = {{Pharmacogenomics}},
title = {{Analyzing array data using supervised methods}},
url = {{http://dx.doi.org/10.1517/14622416.3.3.403}},
doi = {{10.1517/14622416.3.3.403}},
volume = {{3}},
year = {{2002}},
}